Celltrion
068270.KS
#657
Rank
A$46.77 B
Marketcap
$225.83
Share price
0.00%
Change (1 day)
32.54%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: A$46.77 Billion

As of September 2024 Celltrion has a market cap of A$46.77 Billion. This makes Celltrion the world's 657th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Market cap Change
2024A$46.77 B-4.82%
2023A$49.14 B84.45%
2022A$26.64 B-16.45%
2021A$31.88 B-45.5%
2020A$58.51 B106.59%
2019A$28.32 B-19.63%
2018A$35.24 B6.89%
2017A$32.97 B118.62%
2016A$15.08 B35.92%
2015A$11.09 B151.23%
2014A$4.41 B10.43%
2013A$3.99 B-4.58%
2012A$4.19 B17.69%
2011A$3.56 B4.58%
2010A$3.40 B130.93%
2009A$1.47 B26.26%
2008A$1.16 B5362.17%
2007A$21.38 M

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Celltrion was reported to be:

A$46.77 Billion
by Yahoo Finance info icon info icon
A$46.77 Billion
by CompaniesMarketCap info icon info icon